XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Acquisitions of Businesses (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Acquisitions of Businesses [Abstract] |
Clinic Acquisition | During the three months ended March 31, 2024, the Company acquired a majority interest in the following businesses: 2024 Acquisitions
|  |  |  | % Interest |  |  | Number of |
Acquisition |  | Date |  | Acquired |  |  | Clinics |
March 2024 Acquisition |  | March 29, 2024 |  |  | 50% |  |  |  | 9 |
2023 Acquisitions
|  |  |  | % Interest |  | Number of |
Acquisition |  | Date |  | Acquired |  | Clinics |
October 2023 Acquisition |  | October 31, 2023 |  |  | ** |  |  | * |
September 2023 Acquisition 1 |  | September 29, 2023 |  |  | 70% |  |  | 4 |
September 2023 Acquisition 2 |  | September 29, 2023 |  |  | 70% |  |  | 1 |
July 2023 Acquisition |  | July 31, 2023 |  |  | 70% |  |  | 7 |
May 2023 Acquisition |  | May 31, 2023 |  |  | 45% |  |  | 4 |
February 2023 Acquisition |  | February 28, 2023 |  |  | 80% |  |  | 1 |
* | IIP business.
** | On October 31, 2023, the Company concurrently acquired 100% of an IIP business and a 55% equity interest in an ergonomics software business.
Purchase Price Allocation |
|  | Physical Therapy |
|  | Operations |
|  | (In thousands) |
Cash paid, net of cash acquired |  | $ | 15,971 |
Seller note |  |  | 500 |
Deferred payments |  |  | - |
Contingent payments |  |  | 500 |
Total consideration |  | $ | 16,971 |
Estimated fair value of net tangible assets acquired: |  |  |  |
Total current assets |  | $ | - |
Total non-current assets |  |  | 476 |
Total liabilities |  |  | (450 | )
Net tangible assets acquired |  |  | 26 |
Customer and referral relationships |  |  | 6,790 |
Non-compete agreement |  |  | 328 |
Tradenames |  |  | 1,672 |
Goodwill |  |  | 25,056 |
Fair value of non-controlling interest (classified as redeemable non-controlling interest) |  |  | (16,901 | )
|  | $ | 16,971 |
The aggregate purchase price for the 2023 acquisitions has been preliminarily allocated as follows:
|  | Physical Therapy |
|  | IIP |  |  | Operations |  |  | Total |
|  | (In thousands) |
Cash paid, net of cash acquired |  | $ | 3,955 |  |  | $ | 22,627 |  |  | $ | 26,582 |
Seller note |  |  | - |  |  |  | 985 |  |  |  | 985 |
Deferred payments |  |  | - |  |  |  | 830 |  |  |  | 830 |
Contingent payments |  |  | - |  |  |  | 200 |  |  |  | 200 |
Total consideration |  | $ | 3,955 |  |  | $ | 24,642 |  |  | $ | 28,597 |
Estimated fair value of net tangible assets acquired: |  |  |  |  |  |  |  |  |  |  |  |
Total current assets |  | $ | 388 |  |  | $ | 1,079 |  |  | $ | 1,467 |
Total non-current assets |  |  | 335 |  |  |  | 3,150 |  |  |  | 3,485 |
Total liabilities |  |  | (41 | ) |  |  | (3,138 | ) |  |  | (3,179 | )
Net tangible assets acquired |  |  | 682 |  |  |  | 1,091 |  |  |  | 1,773 |
Customer and referral relationships |  |  | 757 |  |  |  | 7,285 |  |  |  | 8,042 |
Non-compete agreement |  |  | 37 |  |  |  | 359 |  |  |  | 396 |
Tradenames |  |  | 187 |  |  |  | 1,580 |  |  |  | 1,767 |
Goodwill |  |  | 2,566 |  |  |  | 25,160 |  |  |  | 27,726 |
Fair value of non-controlling interest (classified as redeemable non-controlling interest) |  |  | (274 | ) |  |  | (10,833 | ) |  |  | (11,107 | )
|  | $ | 3,955 |  |  | $ | 24,642 |  |  | $ | 28,597 |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination. + References No definition available. + Details
Name: | us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration